Neuland Laboratories Ltd (NEUL)

Currency in INR
21,102.00
-353.00(-1.65%)
Closed·
Advertisement
NEULANDLAB is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
21,019.0021,535.00
52 wk Range
11,500.0024,225.00
Key Statistics
Bid/Ask
21,085.00 / 21,125.00
Prev. Close
21,102
Open
21,400
Day's Range
21,019-21,535
52 wk Range
11,500-24,225
Volume
34.81K
Average Volume (3m)
49.23K
1-Year Change
23.577%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
NEULANDLAB Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple

Neuland Laboratories Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Neutral
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Goldman Sachs
Buy17,325.00-17.90%18,800.00Maintain09/02/2026

Neuland Laboratories Ltd Earnings Call Summary for Q2/2027

  • Q2 FY2027 revenue fell 11.4% YoY to INR 457.2cr; profit dropped 47.1% to INR 51.1cr amid cost pressures and shipment timing issues.
  • EBITDA margin compressed to 22.9% from 30.4% YoY; H1 revenue rose 35.5% YoY to INR 1,107.2cr, signaling underlying growth despite volatility.
  • Peptide commercial revenue expected in 1.5-2 years; Phase III pipeline expanded from 8 to 13 projects with record RFP activity this year.
  • Company maintains net cash position of INR 208cr; planning INR 1,700-1,800cr capex over three years including 134-acre Kakinada facility.
  • Top five customers represent 68% of revenue; management cites CDMO lumpiness but affirms FY2027-28 growth outlook remains intact.
Last Updated: 03/11/2026, 13:20
Read Full Transcript

Earnings

Latest Release
03/11/2026
EPS / Forecast
40.20 / 69.51
Revenue / Forecast
4.5B / 4.85B
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 352.74
Dividend Yield
0.16%
Industry Median 0.63%
Annualised payout
34.00
Paid annually
5-Years Growth
+46.72%
Growth Streak

Compare NEULANDLAB to Peers and Sector

Metrics to compare
NEULANDLAB
Peers
Sector
Relationship
P/E Ratio
59.8x28.0x−0.2x
PEG Ratio
0.690.570.00
Price/Book
13.3x4.9x2.6x
Price / LTM Sales
11.7x4.6x2.7x
Upside (Analyst Target)
16.9%11.7%69.6%
Fair Value Upside
Unlock−0.3%11.7%Unlock

Neuland Laboratories Limited engages in the manufacture and sale of active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. It also provides custom manufacturing solutions, generic drug substances, as well as peptide APIs and synthesis services. The company serves generic companies, regional and domestic pharmaceutical manufacturers, distributors, and other pharmaceutical and biotechnology companies. Neuland Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.

Employees
2183
Market
India

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
2.84M22.13%60.91B
Other Institutional Investors
5.01M39.05%107.48B
Public Companies & Retail Investors
4.98M38.82%106.87B
Total
12.83M100.00%275.27B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Davuluri Ownership Trust25.98%3,333,35271,517,067
Malabar Investments5.06%648,73713,918,652

People Also Watch

3,977.10
ACUA
-0.36%
4,205.40
NETE
+2.12%
637.85
TDPS
+0.88%
1,819.60
RRKA
-0.13%
20,443.00
FORC
+1.77%

FAQ

What Is the Neuland Laboratories (NSE: NEULANDLAB) Share Price Today?

The Neuland Laboratories stock price today is 21,102.00 INR.

What Stock Exchange Does Neuland Laboratories (NEULANDLAB) Trade On?

Neuland Laboratories is listed and trades on the India National Stock Exchange.

What Is the Ticker (Stock Symbol) for Neuland Laboratories?

The stock symbol (also called a 'ticker') for Neuland Laboratories is "NEULANDLAB."

Does Neuland Laboratories Pay Dividends? What’s The Current NEULANDLAB Dividend Yield?

Yes, NEULANDLAB Pays Dividends to its Shareholders. The current Neuland Laboratories dividend yield is 0.2%%.

What Is the Current Neuland Laboratories Market Capitalisation?

As of today, Neuland Laboratories (NSE: NEULANDLAB) market cap is 270.62B INR.

What Is Neuland Laboratories's (NEULANDLAB) Earnings Per Share (TTM)?

The Neuland Laboratories EPS is currently 352.74 (Trailing Twelve Months).

When Is the Next Neuland Laboratories Earnings Date?

Neuland Laboratories's next earnings report will be released on 15/02/2027.

Is NEULANDLAB a Buy or Sell From a Technical Analyst Perspective?

Based on today's Neuland Laboratories moving averages and other technical indicators, the daily buy/sell signal for NEULANDLAB stock is Strong Buy.

How Many Times Has Neuland Laboratories Stock Split?

Neuland Laboratories has split 2 times. (See the NEULANDLAB stock split history page for full effective split date and price information.)

How Many Employees Does Neuland Laboratories Have?

Neuland Laboratories has 2183 employees, based on their latest Companies House report.

What is the current trading status of Neuland Laboratories (NSE: NEULANDLAB)?

As of 19/11/2026, Neuland Laboratories (NEULANDLAB) is trading at a share price of 21,102.00 INR, with a previous close of 21,102.00 INR. The stock has fluctuated within a day range of 21,019.00 INR to 21,535.00 INR, while its 52-week range spans from 11,500.00 INR to 24,225.00 INR.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.